Viracta Therapeutics Inc (NASDAQ:VIRX)
| 1.57 Delayed Data As of Mar 28 |  +0.20 / +14.49%Today’s Change | 1.21 Today|||52-Week Range 5.75 | +7.53% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Royston Ivor President & Chief Executive Officer |  Sale | 8/26/2022 | 13,379 | $4.01 | $53.6K | -61.93% |
Royston Ivor President & Chief Executive Officer | Sale | 5/26/2022 | 13,162 | $1.90 | $25.0K | -24.76% |
Chevallard Daniel R Chief Financial & Operating Officer | Sale | 8/26/2022 | 3,655 | $4.02 | $14.7K | -61.93% |
Chevallard Daniel R Chief Financial & Operating Officer | Sale | 11/28/2022 | 3,532 | $2.72 | $9.6K | -37.30% |
Rojkjaer Lisa Chief Medical Officer | Sale | 8/26/2022 | 2,190 | $4.01 | $8.8K | -61.93% |
Chevallard Daniel R Chief Financial & Operating Officer | Sale | 5/26/2022 | 3,596 | $1.90 | $6.8K | -24.76% |
Chevallard Daniel R Chief Financial & Operating Officer | Sale | 2/27/2023 | 3,599 | $1.68 | $6.0K | -5.39% |
Rojkjaer Lisa Chief Medical Officer | Sale | 11/28/2022 | 2,116 | $2.72 | $5.8K | -37.30% |
Rojkjaer Lisa Chief Medical Officer | Sale | 5/26/2022 | 2,154 | $1.90 | $4.1K | -24.76% |
Rojkjaer Lisa Chief Medical Officer | Sale | 2/27/2023 | 2,156 | $1.68 | $3.6K | -5.39% |
Page of 3